Others notice nothing yet
enforcement is tightening with limited discretion to avoid treatment disruption
PMID: Summary Keywords Crohns disease, GLP, GLP-1, GLP-2 receptor agonist, IBD - inflammatory bowel disease, ulcerative colitis Citation Lee JJ, Bajgain P and Lightner AL (2026) GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity
In addition to the pain achievement, retatrutide improved measures of physical function, reduced cardiovascular risk and blood pressure
But the aggressive fragrance takes away from the experience and makes it harder to recommend, especially to the people it's supposedly designed for